• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

Ginsenoside C-K

Ginsenoside C-K (Ginsenoside K) 是 Ginsenoside Rb1 的细菌代谢物，可通过抑制诱生型一氧化氮合酶和COX-2来发挥抗炎作用。它在人肝微粒体中抑制CYP2C9和CYP2A6活性，IC50分别为 32.0±3.6 和 63.6±4.2 μM。

CAS号

39262-14-1

分子式

C36H62O8

主要靶点

P450|COX|cell cycle arrest|NO Synthase

仅限科研使用

Cat No : CM03543

Print datasheet

Synonyms

人参皂苷 C-K|20(S)-人参皂苷 C-K|Ginsenoside compound K|Ginsenoside K

验证数据展示

  • CAS No.: 39262-14-1

    Ginsenoside C-K
    CAS#: 39262-14-1

产品信息

Ginsenoside C-K is a bacterial metabolite of G-Rb1 exhibiting anti-inflammatory effects by reducing iNOS and COX-2.

CAS号 39262-14-1
分子式 C36H62O8
主要靶点 P450|COX|cell cycle arrest|NO Synthase
主要通路 神经科学|代谢|细胞周期|免疫与炎症
分子量 622.88
纯度 99.65%， 此纯度可做参考，具体纯度与批次有关系，可咨询客服
储存条件 Powder: -20°C for 3 years | In solvent: -80°C for 1 year
别名 人参皂苷 C-K|20(S)-人参皂苷 C-K|Ginsenoside compound K|Ginsenoside K

靶点活性

CYP2C9:32.0±3.6 μM|CYP2A6:63.6±4.2 μM

溶解度

DMSO:160.5 mM

参考文献

1.Yang XD,et al. A review of biotransformation and pharmacology of ginsenoside compound K. Fitoterapia. 2015 Jan;100:208-20.
2.Mathiyalagan R,et al. Ginsenoside compound K-bearing glycol chitosan conjugates: synthesis, physicochemical characterization, and in vitro biological studies.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
=
×
×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
×
=
×
C1   V1   C2   V2